A
-
Acute Myeloid Leukemia
The expression level of aspartate beta-hydroxylase (ASPH) and clinical importance in acute myeloid leukemia [Volume 33, Issue 1, 2021]
-
Adult
The expression level of aspartate beta-hydroxylase (ASPH) and clinical importance in acute myeloid leukemia [Volume 33, Issue 1, 2021]
C
-
Carotid intima-media thickness
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
D
-
Diabetes mellitus
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
E
-
Egypt
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
-
Egypt
Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients [Volume 33, Issue 1, 2021]
H
-
Hypertension
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
M
-
Multiple sclerosis
Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients [Volume 33, Issue 1, 2021]
O
-
Osteopontin
Serum osteopontin as a blood biomarker in relapsing–remitting multiple sclerosis Egyptian patients [Volume 33, Issue 1, 2021]
P
-
Protein C
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
-
Protein S
The beneficial therapeutic effects of statins, angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers on protein-C and protein-S activities in Egyptian patients with type-2 diabetes mellitus [Volume 33, Issue 1, 2021]
Your query does not match with any item